GoldenGolden

Immutep

Immutep is a biomedical engineering company.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Ben Adams
June 21, 2021
FierceBiotech
Australian biotech Immutep has secured $60 million Australian dollars through a "two-tranche institutional placement" as it eyes a deeper push into the clinic and looks to raise a further AU$5 million via a share purchase plan.
Isabelle Lee
April 8, 2021
markets.businessinsider.com
A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Sarah Silbiger/Getty Im...
Ben Adams
January 22, 2021
FierceBiotech
It's not been a great week for GlaxoSmithKline's partnered R&D projects; after being forced to cull a major lung cancer trial with Merck KGaA, it's now a case of déjà vu as it axes yet another experimental drug study.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.